HSBC HOLDINGS PLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 119 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$105,000
+31.2%
15,890
+33.1%
0.00%
Q3 2020$80,000
-30.4%
11,936
-13.7%
0.00%
Q2 2020$115,000
+3.6%
13,835
-4.7%
0.00%
Q1 2020$111,000
+12.1%
14,518
+21.6%
0.00%
Q4 2019$99,000
-1.0%
11,936
-11.8%
0.00%
Q3 2019$100,000
-55.0%
13,532
+39.2%
0.00%
Q2 2018$222,0009,7180.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders